Trade AbbVie ^ABBV

The Bull Case For AbbVie (ABBV) Could Change Following Its New AI-Driven US Manufacturing And CLL Win

Mufg Securities Americas Inc. Acquires 8,490 Shares of AbbVie Inc. $ABBV - Stock Observer

FDA Approves AbbVie (ABBV) VENCLEXTA and Acalabrutinib Combination for First-Line CLL

Barclays Initiates AbbVie (ABBV) with Overweight Rating on Growth Potential

AbbVie invests $380 million to expand U.S. API manufacturing

AbbVie to invest $380 million to expand US manufacturing in Illinois

Best Pharmaceutical Stocks To Follow Today - February 22nd - Markets Daily

AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States | Morningstar

Crown Castle and AT&T Tumble While Coca-Cola Rises as Dividened Stocks Take a Breather - 24/7 Wall St.

Zevin Asset Management LLC Cuts Stock Position in AbbVie Inc. $ABBV

CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex | Morningstar

Payden & Rygel Acquires 57,300 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Zevin Asset Management LLC - Stock Observer

Top Medical Stocks To Consider - February 20th - Markets Daily

ABBV: Future Returns Will Rely On Immunology Encore And Evolving Deal Optionality

AbbVie Inc. $ABBV Shares Sold by Sigma Planning Corp

AbbVie Inc. $ABBV Shares Acquired by Lansforsakringar Fondforvaltning AB publ

Channing Capital Management LLC Increases Stake in AbbVie Inc. $ABBV

AbbVie (NYSE:ABBV) Upgraded to Strong-Buy at Barclays

Fiera Capital Corp Has $38.12 Million Stake in AbbVie Inc. $ABBV

Siligmueller & Norvid Wealth Advisors LLC Makes New Investment in AbbVie Inc. $ABBV - Daily Political

Kovack Advisors Inc. Sells 3,229 Shares of AbbVie Inc. $ABBV

FDA OKs AbbVie/Genentech/AstraZeneca Drug Combo in First-Line CLL | Morningstar

AbbVie Inc. $ABBV Shares Sold by China Universal Asset Management Co. Ltd.

Wealth Alliance LLC Reduces Holdings in AbbVie Inc. $ABBV - Daily Political

AbbVie Inc. (NYSE:ABBV) Declares Quarterly Dividend of $1.73

AbbVie (NYSE:ABBV) Trading Down 2% - Here's What Happened

AbbVie Declares Quarterly Dividend PR Newswire NORTH CHICAGO

Cumberland Partners Ltd Acquires 19,130 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Position Raised by L & S Advisors Inc

NewEdge Wealth LLC Acquires 75,364 Shares of AbbVie Inc. $ABBV

Signet Financial Management LLC Cuts Stake in AbbVie Inc. $ABBV

Cornerstone Advisors LLC Sells 2,200 Shares of AbbVie Inc. $ABBV - Stock Observer

Ontario Teachers Pension Plan Board Buys Shares of 235,747 AbbVie Inc. $ABBV - Daily Political

AbbVie Conference: Year-End HS Readouts, SubQ SKYRIZI Data and New IBD Combo Roadmap in Focus - Stock Observer

Evercore Notes AbbVie Inc.'s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited

Analysts Set AbbVie Inc. (NYSE:ABBV) PT at $251.00 - Daily Political

Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases

Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocks

AbbVie (NYSE:ABBV) Shares Down 1.7% - Here's What Happened

Dividend large caps Microsoft, AbbVie and PNC tied to AI

Calls of the Day: First Solar, Abbvie, Amgen, Ulta and Costco

AbbVie Inc. $ABBV Shares Acquired by Ingalls & Snyder LLC - Markets Daily

Waycross Partners LLC Purchases 8,077 Shares of AbbVie Inc. $ABBV

Ingalls & Snyder LLC Increases Stock Position in AbbVie Inc. $ABBV

Advisors Capital Management LLC Boosts Stock Holdings in AbbVie Inc. $ABBV - Daily Political

Facial Injectable Analysis Report 2025: An $18.89 Billion Market by 2029, Driven by New Product Launches, Emerging Markets, AI Innovations, Male Aesthetics, Younger Demographics

AbbVie Inc. $ABBV Shares Bought by NEOS Investment Management LLC

AbbVie Inc. $ABBV Shares Purchased by Colrain Capital LLC

Glenview Trust Co Has $95.89 Million Stake in AbbVie Inc. $ABBV

Arvest Bank Trust Division Cuts Stock Position in AbbVie Inc. $ABBV

A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia

Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma

MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D

AbbVie Inc. $ABBV Position Boosted by Southeast Asset Advisors LLC

AbbVie Inc. $ABBV Shares Sold by M&G PLC | MarketBeat

AbbVie Inc. $ABBV Stake Cut by Zions Bancorporation National Association UT

Vanguard Group Inc. Acquires 448,554 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Acquired by Fifth Third Bancorp

Todd Asset Management LLC Lowers Stock Position in AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc. (NYSE:ABBV) Given Consensus Rating of "Moderate Buy" by Analysts

AbbVie Inc. $ABBV Shares Purchased by Capital Planning Advisors LLC - Stock Observer

AbbVie Conference: Year-End HS Readouts, SubQ SKYRIZI Data and New IBD Combo Roadmap in Focus - Daily Political

1 No-Brainer Dividend Stock to Buy on the Dip

Shell Asset Management Co. Trims Stake in AbbVie Inc. $ABBV - Markets Daily

Top Pharmaceutical Stocks To Watch Now - February 15th - Stock Observer

AbbVie (NYSE:ABBV) Shares Up 1.8% - Here's Why - Markets Daily

AbbVie Inc. $ABBV Stock Holdings Boosted by PNC Financial Services Group Inc. - Markets Daily

Investment Partners LTD. Sells 13,247 Shares of AbbVie Inc. $ABBV

HighTower Advisors LLC Raises Stock Holdings in AbbVie Inc. $ABBV

GF Fund Management CO. LTD. Purchases 5,709 Shares of AbbVie Inc. $ABBV

Assetmark Inc. Increases Stock Position in AbbVie Inc. $ABBV

2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off - AOL

WJ Financial Advisors LLC Makes New $557,000 Investment in AbbVie Inc. $ABBV - Markets Daily

Is It Too Late To Consider AbbVie (ABBV) After Its Strong Multi‑Year Share Price Run?

AbbVie Inc. $ABBV Shares Acquired by BTC Capital Management Inc. - Markets Daily

DDD Partners LLC Cuts Stock Position in AbbVie Inc. $ABBV

CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis

AbbVie (NYSE:ABBV) Trading 1.8% Higher - Time to Buy?

AbbVie (NYSE:ABBV) Stock Price Up 1.8% - Here's What Happened - Stock Observer

Glenmark's 25-Year Journey: From Challenges to $1.9 Billion AbbVie Deal, ETPharma

Where is AbbVie Inc. (ABBV) Headed According to the Street?

Metis Global Partners LLC Has $22.53 Million Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Purchased by Public Sector Pension Investment Board

Aldeyra's Dry Eye Therapy Faces FDA In March - Will The Third Time Be A Charm?

Freemont Management S.A. Trims Stake in AbbVie Inc. $ABBV

Capital Investment Counsel LLC Sells 2,482 Shares of AbbVie Inc. $ABBV - Daily Political

Pharmaceutical Stocks To Watch Today - February 12th - Stock Observer

Savvy Advisors Inc. Raises Holdings in AbbVie Inc. $ABBV

AbbVie Inc. (ABBV) Achieves Record Net Sales on Diversified Growth Platform

Atria Investments Inc Decreases Stake in AbbVie Inc. $ABBV

Varma Mutual Pension Insurance Co Has $61 Million Stake in AbbVie Inc. $ABBV - Daily Political

Abbvie claims CMS' selection of Botox violates the IRA | BioWorld

AbbVie sues US health agency over Botox price controls

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Week Ahead: China Is On Holiday, But The BoC, The Fed, And The ECB Will Be Busy With The First 2025 Rate Announcements 

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Fed, ECB & BoJ in action

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk